AVNS
Avanos Medical Inc
25.00$
+0.0%
vs. previous close
Closing price · As of: Jul 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3.5% | -1.9% | -1.8% | -0.2% | -0.1% | -30.3% | -4.0% | -6.2% | +2.8% | +0.6% | -2.2% | |
| – | +3.5% | -7.2% | -3.9% | +1.3% | -0.3% | -16.8% | -10.4% | +1.0% | -1.3% | +1.1% | -8.6% | |
| – | +30.9% | -18.1% | -13.6% | +21.6% | -3.5% | +21.0% | -9.9% | -6.9% | -21.9% | +27.4% | -26.9% | |
| – | +30.9% | -18.1% | -13.6% | +21.6% | -3.5% | +21.0% | -9.9% | -6.9% | -21.9% | +27.4% | -26.9% | |
| – | -4.7% | -1.7% | -8.1% | -6.3% | +7.2% | +0.7% | -21.1% | +5.2% | +1.0% | -6.7% | -0.8% | |
| – | +5.6% | +4.2% | +1.5% | -1.0% | -1.2% | -14.3% | -0.5% | +3.3% | +5.5% | -1.7% | -4.5% | |
| – | +17.4% | – | – | – | – | – | – | – | – | – | – | |
| – | +3.8% | +0.6% | -0.2% | -0.1% | +0.1% | -42.7% | +0.1% | -16.4% | +3.5% | +0.1% | -0.2% | |
| – | +8.8% | -1.1% | -2.8% | -2.8% | -2.7% | -49.0% | -4.5% | -1.7% | +15.7% | -3.4% | -2.6% | |
| – | +16.4% | -9.3% | -5.0% | +0.6% | -2.1% | -23.6% | -17.6% | -2.1% | +10.3% | +2.0% | -9.3% | |
| – | +6.4% | +37.4% | -12.5% | +1.5% | +2.3% | -22.1% | -17.3% | -1.9% | +9.9% | +11.7% | -20.6% | |
| – | -4.1% | +13.2% | -2.3% | +17.7% | -6.1% | -12.1% | -2.5% | +0.0% | -4.5% | -2.6% | +15.8% | |
| – | -20.3% | +8.1% | +1.2% | -9.8% | +5.4% | +0.2% | -15.3% | +6.1% | +11.1% | +2.4% | -5.8% | |
| – | +27.1% | -38.3% | +4.9% | -1.4% | -7.5% | -17.9% | -21.8% | -2.3% | -2.4% | -3.3% | -3.3% | |
| – | -1.0% | +1.2% | -0.7% | -0.5% | +0.6% | -32.6% | +1.3% | -7.5% | +0.2% | +0.0% | +0.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -0.4% | -0.9% | +0.2% | +0.6% | -1.3% | +1.7% | +0.0% | -0.9% | +0.0% | +0.0% |
Data as of: July 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.